Mechanisms of Vascular Tone Regulation
The pharmacological effect of adrenolytics is largely determined by how specific receptors normally respond to neurotransmitters of the sympathetic nervous system.
- Postsynaptic $\alpha_1$-adrenoreceptors. Under physiological conditions, their stimulation causes vasoconstriction. Consequently, the pharmacological blockade of $\alpha_1$-receptors eliminates this prevailing sympathetic tone, predictably leading to vasodilation.
- Postsynaptic $\beta_2$-adrenoreceptors. Their stimulation normally induces relaxation of the vascular smooth muscle. Blocking $\beta_2$-receptors completely shuts down this natural relaxation mechanism. Importantly, $\beta_2$-blockade not only fails to promote vasodilation, but it may also provoke vasospasm because $\alpha$-receptor tone remains unopposed.
- Presynaptic $\alpha_2$-adrenoreceptors. These structures act as a negative feedback brake mechanism. When blocked, this normal control is disrupted, and an excess of norepinephrine is released into the synaptic cleft. This excess neurotransmitter will prevent vasodilation unless postsynaptic receptors are reliably blocked.
Clinical Comparison: Propranolol and Prazosin
Differences in mechanisms of action dictate completely distinct clinical niches for specific drugs. A classic example is the comparison between a non-selective $\beta$-blocker and a selective $\alpha_1$-blocker.
Propranolol A classic non-selective agent (blocks both $\beta_1$- and $\beta_2$-receptors).
- Main effects: Lowers blood pressure (antihypertensive action), possesses antianginal and antiarrhythmic activity.
- Indications: Successfully used in stable angina, supraventricular arrhythmias, management of thyroid storm, hypertension, and even migraine prophylaxis.
- Limitations: The primary drawback is impaired peripheral circulation. This occurs precisely due to the non-selective blockade of vascular $\beta_2$-receptors, which can lead to vasospasm.
- Prazosin
A selective $\alpha_1$-adrenoreceptor blocker.
- Mechanism: Causes direct vasodilation of both peripheral arteries and veins.
- Advantages: Unlike propranolol, prazosin does not cause vasospasm; rather, it effectively relieves it. Therefore, the drug is indicated for peripheral arterial diseases accompanied by ischemia (e.g., Raynaud's phenomenon or thromboangiitis obliterans).
Drug Selection in Comorbid Pathology: Bronchial Asthma
Coexisting bronchial asthma fundamentally changes the approach to prescribing adrenolytics, particularly in the management of hypertension. The main issue is that blocking $\beta_2$-adrenoreceptors in the bronchi inevitably provokes severe bronchospasm.
Safety analysis of various drug groups:
- Non-selective $\beta$-blockers (propranolol, carvedilol). Block receptors of both types ($\beta_1$ and $\beta_2$). They are strictly contraindicated in patients with asthma.
- Selective $\beta_1$-blockers (metoprolol, bisoprolol). Considered less hazardous because they predominantly affect the heart. However, their selectivity is not absolute: at high doses, it is lost, and the drugs begin to block $\beta_2$-receptors. They must be prescribed with extreme caution and strict monitoring in these patients.
- Selective $\alpha_1$-blockers (doxazosin). Act exclusively on the vascular bed and have no effect on bronchial smooth muscle tone.
Thus, the optimal strategy for treating hypertension in a patient with asthma is to select drugs that do not affect $\beta_2$-receptors, such as doxazosin. If a $\beta$-blocker is required, only highly selective $\beta_1$-agents are permissible. (Tamsulosin also exists, but it exhibits pronounced uroselectivity and is typically not used in cardiology to lower blood pressure).